TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma
TAS0313联合帕博利珠单抗治疗化疗后未接受过免疫检查点抑制剂治疗的局部晚期或转移性尿路上皮癌
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0187
Nishiyama, Hiroyuki; Yonese, Junji; Kawahara, Takashi; Matsumoto, Ryuji; Miyake, Hideaki; Matsubara, Nobuaki; Uemura, Hiroji; Eto, Masatoshi; Azuma, Haruhito; Obara, Wataru; Terai, Akito; Fukasawa, Satoshi; Suekane, Shigetaka